Use of the Bradykinin Agonist, Cereport as a Pharmacological Means of Increasing Drug Delivery to the CNS
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
109-123
Author(s):
Dwaine F. Emerich
Recent Progress in the Development of Anticancer Agents
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
2
Page:
419-439
Author(s):
Sandor Eckhardt
Non-peptide Antagonists and Agonists of the Bradykinin B2 Receptor
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
913-928
Author(s):
H. Heitsch
Separating Fact from Fiction: Assessing the Potential of Modified Adenovirus Vectors for Use in Human Gene Therapy
Journal:
Current Gene Therapy
Volume:
2
Page:
111-133
Author(s):
Andrea Amalfitano and Robin J. Parks
AMPA Receptor Antagonists with Additional Mechanisms of Action: New Opportunities for Neuroprotective Drugs?
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
941-951
Author(s):
Thomas Weiser
Physiology of Folic Acid in Health and Disease
Journal:
Current Drug Metabolism
Volume:
3
Page:
211-223
Author(s):
O. Stanger
Hyperhomocysteinemia, Pteridines and Oxidative Stress
Journal:
Current Drug Metabolism
Volume:
3
Page:
225-232
Author(s):
B. Widner, C. Enzinger, A. Laich, B. Wirleitner and D. Fuchs
Aspartic Proteinases in Disease: A Structural Perspective
Journal:
Current Drug Targets
Volume:
3
Page:
155-173
Author(s):
J. B. Cooper
Inhibition of BACE, a Promising Approach to Alzheimers Disease Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
2
Page:
359-370
Author(s):
Silvio Roggo
γ-Secretase as a Target for Alzheimers Disease
Journal:
Current Topics in Medicinal Chemistry
Volume:
2
Page:
371-383
Author(s):
Michael S. Wolf